Marleen G H van de Sande (Marleen van der Sande)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Replacement Therapy

Radical Prostatectomy

Clinical Practice

Rheumatoid Arthritis Patients

Top Venues

The Journal of rheumatology

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjær Rasmussen, Lennart Jacobsson, Anne Gitte Loft, Florenzo Iannone, Karen M Fagerli, Jiri Vencovsky, Maria Jose Santos, Burkhard Möller, Manuel Pombo-Suarez, Žiga Rotar, Bjorn Gudbjornsson, Ayse Cefle, Kari Eklund, Catalin Codreanu, Gareth T Jones, Marleen G H van de Sande, Johan Karlsson Wallman, Marco Sebastiani, Brigitte Michelsen, Jakub Závada, Michael John Nissen, Carlos Sánchez-Piedra, Matija Tomšič, Thorvardur Jon Love, Heikki Relas, Corina Mogosan, Merete Lund Hetland, Mikkel Østergaard
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care. The Journal of rheumatology 51 (4) (2024)
Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjær Rasmussen, Lennart Jacobsson, Anne Gitte Loft, Florenzo Iannone, Karen M Fagerli, Jiri Vencovsky, Maria Jose Santos, Burkhard Möller, Manuel Pombo-Suarez, Žiga Rotar, Bjorn Gudbjornsson, Ayse Cefle, Kari Eklund, Catalin Codreanu, Gareth T Jones, Marleen G H van de Sande, Johan Karlsson Wallman, Marco Sebastiani, Brigitte Michelsen, Jakub Závada, Michael John Nissen, Carlos Sánchez-Piedra, Matija Tomšič, Thorvardur Jon Love, Heikki Relas, Corina Mogosan, Merete Lund Hetland, Mikkel Østergaard
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care. The Journal of rheumatology 51 (4) (2024)
Pasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, Ronald F Van Vollenhoven, Rosemary J Hollick, Ovidiu Rotariu, Žiga Rotar, Katja Perdan Pirkmajer, Dan Nordström, Anna-Mari Hokkanen, Brigitte Michelsen, Tore K Kvien, Bente Glintborg, Merete Lund Hetland, Mikkel Østergaard, Anne Gitte Loft, Karel Pavelka, Jakub Závada, Isabel Castrejon, Lucia Otero Varela, Bjorn Gudbjornsson, Olafur Palsson, Tor Olofsson, Johan Karlsson Wallman, Adrian Ciurea, Michael John Nissen, Tuba D Yildirim, Fatoş Önen, Catalin Codreanu, Corina Mogosan, Maria Jose Santos, Elsa Viera Sousa, Florenzo Iannone, Bruno Frediani, Lykke Midtbøll Ørnbjerg, Jos W R Twisk, Irene E van der Horst-Bruinsma
Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors. Rheumatology (Oxford, England) (2024)
Janne W Bolt, Caroline J Aalbers, Laura Walet, Leonieke J J van Mens, Christiaan van Denderen, Irene van der Horst-Bruinsma, Lisa G M van Baarsen, Robert Landewé, Marleen G H van de Sande
Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target. Rheumatology (Oxford, England) (2023)